Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy

NCT03181646 is registered in ClinicalTrials.gov with Armed Forces Hospital, Pakistan as lead sponsor.

NCT NCT03181646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03181646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy
Lead sponsor
Armed Forces Hospital, Pakistan
Phase
Phase 3
Overall status
Unknown status
Start date
June 15, 2017
Completion date
December 15, 2017
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy